MobiHealth News February 9, 2024
The digital cytology system helps identify cervical cancer cells and precancerous lesions using deep learning AI and volumetric imaging technology.
Medical technology firm Hologic has been granted clearance from the FDA to market its Genius Digital Diagnostics System, powered by the company’s Genius Cervical AI algorithm.
The digital cytology system–a medical diagnostic tool used to examine cells under a microscope to detect abnormalities or diseases–integrates deep learning-based AI with advanced volumetric imaging technology to aid in detecting precancerous lesions and cervical cancer cells.
Its commercial launch is expected later this year. Its technology is already available in Europe, Australia and New Zealand.
Cervical cancer screenings typically involve a Pap test, where cervical cell samples are collected at an OB-GYN office...
Today's Sponsors
Today's Sponsor
